Global Prenatal Screening Market 2026 by Company, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global Prenatal Screening market size was valued at US$ 5031 million in 2025 and is forecast to a readjusted size of US$ 7887 million by 2032 with a CAGR of 6.7% during review period.
Prenatal Screening refers to the set of tests offered during pregnancy to assess the likelihood that a fetus has certain genetic, chromosomal, or congenital conditions before birth. It typically uses maternal blood measurements and imaging assessments, and in some models genetic analysis of pregnancy related biomarkers, to stratify risk and determine whether follow-up diagnostic testing and specialist consultation are needed.
The prenatal screening market is driven by the growing clinical and social preference for earlier risk visibility during pregnancy, alongside rapid innovation in testing methods and service delivery models. Demand is supported by routine integration into obstetric care pathways, while adoption and pricing are shaped by clinical guidelines, reimbursement coverage, and ethical governance. Competitive dynamics increasingly favor providers and manufacturers that can offer high analytical performance, fast turnaround, and strong counseling and referral support, because screening value depends on downstream decision making rather than the test result alone. Over time, market growth is likely to be led by mix shift toward more comprehensive screening portfolios and digitally enabled patient management, even as competition and payer scrutiny push vendors to demonstrate clear clinical utility and cost effectiveness.
This report is a detailed and comprehensive analysis for global Prenatal Screening market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Prenatal Screening market size and forecasts, in consumption value ($ Million), 2021-2032
Global Prenatal Screening market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Prenatal Screening market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Prenatal Screening market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Prenatal Screening market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Prenatal Screening product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Prenatal Screening, with revenue, gross margin, and global market share of Prenatal Screening from 2021 to 2026.
Chapter 3, the Prenatal Screening competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Prenatal Screening market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Prenatal Screening.
Chapter 13, to describe Prenatal Screening research findings and conclusion.
Prenatal Screening refers to the set of tests offered during pregnancy to assess the likelihood that a fetus has certain genetic, chromosomal, or congenital conditions before birth. It typically uses maternal blood measurements and imaging assessments, and in some models genetic analysis of pregnancy related biomarkers, to stratify risk and determine whether follow-up diagnostic testing and specialist consultation are needed.
The prenatal screening market is driven by the growing clinical and social preference for earlier risk visibility during pregnancy, alongside rapid innovation in testing methods and service delivery models. Demand is supported by routine integration into obstetric care pathways, while adoption and pricing are shaped by clinical guidelines, reimbursement coverage, and ethical governance. Competitive dynamics increasingly favor providers and manufacturers that can offer high analytical performance, fast turnaround, and strong counseling and referral support, because screening value depends on downstream decision making rather than the test result alone. Over time, market growth is likely to be led by mix shift toward more comprehensive screening portfolios and digitally enabled patient management, even as competition and payer scrutiny push vendors to demonstrate clear clinical utility and cost effectiveness.
This report is a detailed and comprehensive analysis for global Prenatal Screening market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Prenatal Screening market size and forecasts, in consumption value ($ Million), 2021-2032
Global Prenatal Screening market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Prenatal Screening market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Prenatal Screening market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
- To determine the size of the total market opportunity of global and key countries
- To assess the growth potential for Prenatal Screening
- To forecast future growth in each product and end-use market
- To assess competitive factors affecting the marketplace
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Prenatal Screening market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Serum Biomarker Screening
- Ultrasonographic Imaging Screening
- Others
- First-trimester Screening
- Second-trimester Screening
- Late-pregnancy Screening
- Public Health Program
- Consumer
- Others
- Public Hospitals
- Private Hospitals
- Thermo Fisher Scientific
- Revvity
- Quest Diagnostics
- MedGenome
- Mayo Clinic Laboratories
- GeneDx
- PreventionGenetics
- SYNLAB
- Veritas Genetics
- GGA
- Cordlife
- Rainbow Genomics
- BGI Genomics
- Berry Genomics
- Annaroad
- Jiajian Medical Testing
- Genesky
- Weihansi Biomedical Technology
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Prenatal Screening product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Prenatal Screening, with revenue, gross margin, and global market share of Prenatal Screening from 2021 to 2026.
Chapter 3, the Prenatal Screening competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Prenatal Screening market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Prenatal Screening.
Chapter 13, to describe Prenatal Screening research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Prenatal Screening by Type
1.3.1 Overview: Global Prenatal Screening Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Prenatal Screening Consumption Value Market Share by Type in 2025
1.3.3 Serum Biomarker Screening
1.3.4 Ultrasonographic Imaging Screening
1.3.5 Others
1.4 Classification of Prenatal Screening by Screening Timing
1.4.1 Overview: Global Prenatal Screening Market Size by Screening Timing: 2021 Versus 2025 Versus 2032
1.4.2 Global Prenatal Screening Consumption Value Market Share by Screening Timing in 2025
1.4.3 First-trimester Screening
1.4.4 Second-trimester Screening
1.4.5 Late-pregnancy Screening
1.5 Classification of Prenatal Screening by Service Model
1.5.1 Overview: Global Prenatal Screening Market Size by Service Model: 2021 Versus 2025 Versus 2032
1.5.2 Global Prenatal Screening Consumption Value Market Share by Service Model in 2025
1.5.3 Public Health Program
1.5.4 Consumer
1.5.5 Others
1.6 Global Prenatal Screening Market by Application
1.6.1 Overview: Global Prenatal Screening Market Size by Application: 2021 Versus 2025 Versus 2032
1.6.2 Public Hospitals
1.6.3 Private Hospitals
1.7 Global Prenatal Screening Market Size & Forecast
1.8 Global Prenatal Screening Market Size and Forecast by Region
1.8.1 Global Prenatal Screening Market Size by Region: 2021 VS 2025 VS 2032
1.8.2 Global Prenatal Screening Market Size by Region, (2021-2032)
1.8.3 North America Prenatal Screening Market Size and Prospect (2021-2032)
1.8.4 Europe Prenatal Screening Market Size and Prospect (2021-2032)
1.8.5 Asia-Pacific Prenatal Screening Market Size and Prospect (2021-2032)
1.8.6 South America Prenatal Screening Market Size and Prospect (2021-2032)
1.8.7 Middle East & Africa Prenatal Screening Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 Thermo Fisher Scientific
2.1.1 Thermo Fisher Scientific Details
2.1.2 Thermo Fisher Scientific Major Business
2.1.3 Thermo Fisher Scientific Prenatal Screening Product and Solutions
2.1.4 Thermo Fisher Scientific Prenatal Screening Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.2 Revvity
2.2.1 Revvity Details
2.2.2 Revvity Major Business
2.2.3 Revvity Prenatal Screening Product and Solutions
2.2.4 Revvity Prenatal Screening Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Revvity Recent Developments and Future Plans
2.3 Quest Diagnostics
2.3.1 Quest Diagnostics Details
2.3.2 Quest Diagnostics Major Business
2.3.3 Quest Diagnostics Prenatal Screening Product and Solutions
2.3.4 Quest Diagnostics Prenatal Screening Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Quest Diagnostics Recent Developments and Future Plans
2.4 MedGenome
2.4.1 MedGenome Details
2.4.2 MedGenome Major Business
2.4.3 MedGenome Prenatal Screening Product and Solutions
2.4.4 MedGenome Prenatal Screening Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 MedGenome Recent Developments and Future Plans
2.5 Mayo Clinic Laboratories
2.5.1 Mayo Clinic Laboratories Details
2.5.2 Mayo Clinic Laboratories Major Business
2.5.3 Mayo Clinic Laboratories Prenatal Screening Product and Solutions
2.5.4 Mayo Clinic Laboratories Prenatal Screening Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Mayo Clinic Laboratories Recent Developments and Future Plans
2.6 GeneDx
2.6.1 GeneDx Details
2.6.2 GeneDx Major Business
2.6.3 GeneDx Prenatal Screening Product and Solutions
2.6.4 GeneDx Prenatal Screening Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 GeneDx Recent Developments and Future Plans
2.7 PreventionGenetics
2.7.1 PreventionGenetics Details
2.7.2 PreventionGenetics Major Business
2.7.3 PreventionGenetics Prenatal Screening Product and Solutions
2.7.4 PreventionGenetics Prenatal Screening Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 PreventionGenetics Recent Developments and Future Plans
2.8 SYNLAB
2.8.1 SYNLAB Details
2.8.2 SYNLAB Major Business
2.8.3 SYNLAB Prenatal Screening Product and Solutions
2.8.4 SYNLAB Prenatal Screening Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 SYNLAB Recent Developments and Future Plans
2.9 Veritas Genetics
2.9.1 Veritas Genetics Details
2.9.2 Veritas Genetics Major Business
2.9.3 Veritas Genetics Prenatal Screening Product and Solutions
2.9.4 Veritas Genetics Prenatal Screening Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Veritas Genetics Recent Developments and Future Plans
2.10 GGA
2.10.1 GGA Details
2.10.2 GGA Major Business
2.10.3 GGA Prenatal Screening Product and Solutions
2.10.4 GGA Prenatal Screening Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 GGA Recent Developments and Future Plans
2.11 Cordlife
2.11.1 Cordlife Details
2.11.2 Cordlife Major Business
2.11.3 Cordlife Prenatal Screening Product and Solutions
2.11.4 Cordlife Prenatal Screening Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Cordlife Recent Developments and Future Plans
2.12 Rainbow Genomics
2.12.1 Rainbow Genomics Details
2.12.2 Rainbow Genomics Major Business
2.12.3 Rainbow Genomics Prenatal Screening Product and Solutions
2.12.4 Rainbow Genomics Prenatal Screening Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Rainbow Genomics Recent Developments and Future Plans
2.13 BGI Genomics
2.13.1 BGI Genomics Details
2.13.2 BGI Genomics Major Business
2.13.3 BGI Genomics Prenatal Screening Product and Solutions
2.13.4 BGI Genomics Prenatal Screening Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 BGI Genomics Recent Developments and Future Plans
2.14 Berry Genomics
2.14.1 Berry Genomics Details
2.14.2 Berry Genomics Major Business
2.14.3 Berry Genomics Prenatal Screening Product and Solutions
2.14.4 Berry Genomics Prenatal Screening Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Berry Genomics Recent Developments and Future Plans
2.15 Annaroad
2.15.1 Annaroad Details
2.15.2 Annaroad Major Business
2.15.3 Annaroad Prenatal Screening Product and Solutions
2.15.4 Annaroad Prenatal Screening Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 Annaroad Recent Developments and Future Plans
2.16 Jiajian Medical Testing
2.16.1 Jiajian Medical Testing Details
2.16.2 Jiajian Medical Testing Major Business
2.16.3 Jiajian Medical Testing Prenatal Screening Product and Solutions
2.16.4 Jiajian Medical Testing Prenatal Screening Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 Jiajian Medical Testing Recent Developments and Future Plans
2.17 Genesky
2.17.1 Genesky Details
2.17.2 Genesky Major Business
2.17.3 Genesky Prenatal Screening Product and Solutions
2.17.4 Genesky Prenatal Screening Revenue, Gross Margin and Market Share (2021-2026)
2.17.5 Genesky Recent Developments and Future Plans
2.18 Weihansi Biomedical Technology
2.18.1 Weihansi Biomedical Technology Details
2.18.2 Weihansi Biomedical Technology Major Business
2.18.3 Weihansi Biomedical Technology Prenatal Screening Product and Solutions
2.18.4 Weihansi Biomedical Technology Prenatal Screening Revenue, Gross Margin and Market Share (2021-2026)
2.18.5 Weihansi Biomedical Technology Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Prenatal Screening Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Prenatal Screening by Company Revenue
3.2.2 Top 3 Prenatal Screening Players Market Share in 2025
3.2.3 Top 6 Prenatal Screening Players Market Share in 2025
3.3 Prenatal Screening Market: Overall Company Footprint Analysis
3.3.1 Prenatal Screening Market: Region Footprint
3.3.2 Prenatal Screening Market: Company Product Type Footprint
3.3.3 Prenatal Screening Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Prenatal Screening Consumption Value and Market Share by Type (2021-2026)
4.2 Global Prenatal Screening Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Prenatal Screening Consumption Value Market Share by Application (2021-2026)
5.2 Global Prenatal Screening Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America Prenatal Screening Consumption Value by Type (2021-2032)
6.2 North America Prenatal Screening Market Size by Application (2021-2032)
6.3 North America Prenatal Screening Market Size by Country
6.3.1 North America Prenatal Screening Consumption Value by Country (2021-2032)
6.3.2 United States Prenatal Screening Market Size and Forecast (2021-2032)
6.3.3 Canada Prenatal Screening Market Size and Forecast (2021-2032)
6.3.4 Mexico Prenatal Screening Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe Prenatal Screening Consumption Value by Type (2021-2032)
7.2 Europe Prenatal Screening Consumption Value by Application (2021-2032)
7.3 Europe Prenatal Screening Market Size by Country
7.3.1 Europe Prenatal Screening Consumption Value by Country (2021-2032)
7.3.2 Germany Prenatal Screening Market Size and Forecast (2021-2032)
7.3.3 France Prenatal Screening Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Prenatal Screening Market Size and Forecast (2021-2032)
7.3.5 Russia Prenatal Screening Market Size and Forecast (2021-2032)
7.3.6 Italy Prenatal Screening Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific Prenatal Screening Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Prenatal Screening Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Prenatal Screening Market Size by Region
8.3.1 Asia-Pacific Prenatal Screening Consumption Value by Region (2021-2032)
8.3.2 China Prenatal Screening Market Size and Forecast (2021-2032)
8.3.3 Japan Prenatal Screening Market Size and Forecast (2021-2032)
8.3.4 South Korea Prenatal Screening Market Size and Forecast (2021-2032)
8.3.5 India Prenatal Screening Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Prenatal Screening Market Size and Forecast (2021-2032)
8.3.7 Australia Prenatal Screening Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America Prenatal Screening Consumption Value by Type (2021-2032)
9.2 South America Prenatal Screening Consumption Value by Application (2021-2032)
9.3 South America Prenatal Screening Market Size by Country
9.3.1 South America Prenatal Screening Consumption Value by Country (2021-2032)
9.3.2 Brazil Prenatal Screening Market Size and Forecast (2021-2032)
9.3.3 Argentina Prenatal Screening Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Prenatal Screening Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Prenatal Screening Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Prenatal Screening Market Size by Country
10.3.1 Middle East & Africa Prenatal Screening Consumption Value by Country (2021-2032)
10.3.2 Turkey Prenatal Screening Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Prenatal Screening Market Size and Forecast (2021-2032)
10.3.4 UAE Prenatal Screening Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 Prenatal Screening Market Drivers
11.2 Prenatal Screening Market Restraints
11.3 Prenatal Screening Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Prenatal Screening Industry Chain
12.2 Prenatal Screening Upstream Analysis
12.3 Prenatal Screening Midstream Analysis
12.4 Prenatal Screening Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Prenatal Screening by Type
1.3.1 Overview: Global Prenatal Screening Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Prenatal Screening Consumption Value Market Share by Type in 2025
1.3.3 Serum Biomarker Screening
1.3.4 Ultrasonographic Imaging Screening
1.3.5 Others
1.4 Classification of Prenatal Screening by Screening Timing
1.4.1 Overview: Global Prenatal Screening Market Size by Screening Timing: 2021 Versus 2025 Versus 2032
1.4.2 Global Prenatal Screening Consumption Value Market Share by Screening Timing in 2025
1.4.3 First-trimester Screening
1.4.4 Second-trimester Screening
1.4.5 Late-pregnancy Screening
1.5 Classification of Prenatal Screening by Service Model
1.5.1 Overview: Global Prenatal Screening Market Size by Service Model: 2021 Versus 2025 Versus 2032
1.5.2 Global Prenatal Screening Consumption Value Market Share by Service Model in 2025
1.5.3 Public Health Program
1.5.4 Consumer
1.5.5 Others
1.6 Global Prenatal Screening Market by Application
1.6.1 Overview: Global Prenatal Screening Market Size by Application: 2021 Versus 2025 Versus 2032
1.6.2 Public Hospitals
1.6.3 Private Hospitals
1.7 Global Prenatal Screening Market Size & Forecast
1.8 Global Prenatal Screening Market Size and Forecast by Region
1.8.1 Global Prenatal Screening Market Size by Region: 2021 VS 2025 VS 2032
1.8.2 Global Prenatal Screening Market Size by Region, (2021-2032)
1.8.3 North America Prenatal Screening Market Size and Prospect (2021-2032)
1.8.4 Europe Prenatal Screening Market Size and Prospect (2021-2032)
1.8.5 Asia-Pacific Prenatal Screening Market Size and Prospect (2021-2032)
1.8.6 South America Prenatal Screening Market Size and Prospect (2021-2032)
1.8.7 Middle East & Africa Prenatal Screening Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 Thermo Fisher Scientific
2.1.1 Thermo Fisher Scientific Details
2.1.2 Thermo Fisher Scientific Major Business
2.1.3 Thermo Fisher Scientific Prenatal Screening Product and Solutions
2.1.4 Thermo Fisher Scientific Prenatal Screening Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.2 Revvity
2.2.1 Revvity Details
2.2.2 Revvity Major Business
2.2.3 Revvity Prenatal Screening Product and Solutions
2.2.4 Revvity Prenatal Screening Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Revvity Recent Developments and Future Plans
2.3 Quest Diagnostics
2.3.1 Quest Diagnostics Details
2.3.2 Quest Diagnostics Major Business
2.3.3 Quest Diagnostics Prenatal Screening Product and Solutions
2.3.4 Quest Diagnostics Prenatal Screening Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Quest Diagnostics Recent Developments and Future Plans
2.4 MedGenome
2.4.1 MedGenome Details
2.4.2 MedGenome Major Business
2.4.3 MedGenome Prenatal Screening Product and Solutions
2.4.4 MedGenome Prenatal Screening Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 MedGenome Recent Developments and Future Plans
2.5 Mayo Clinic Laboratories
2.5.1 Mayo Clinic Laboratories Details
2.5.2 Mayo Clinic Laboratories Major Business
2.5.3 Mayo Clinic Laboratories Prenatal Screening Product and Solutions
2.5.4 Mayo Clinic Laboratories Prenatal Screening Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Mayo Clinic Laboratories Recent Developments and Future Plans
2.6 GeneDx
2.6.1 GeneDx Details
2.6.2 GeneDx Major Business
2.6.3 GeneDx Prenatal Screening Product and Solutions
2.6.4 GeneDx Prenatal Screening Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 GeneDx Recent Developments and Future Plans
2.7 PreventionGenetics
2.7.1 PreventionGenetics Details
2.7.2 PreventionGenetics Major Business
2.7.3 PreventionGenetics Prenatal Screening Product and Solutions
2.7.4 PreventionGenetics Prenatal Screening Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 PreventionGenetics Recent Developments and Future Plans
2.8 SYNLAB
2.8.1 SYNLAB Details
2.8.2 SYNLAB Major Business
2.8.3 SYNLAB Prenatal Screening Product and Solutions
2.8.4 SYNLAB Prenatal Screening Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 SYNLAB Recent Developments and Future Plans
2.9 Veritas Genetics
2.9.1 Veritas Genetics Details
2.9.2 Veritas Genetics Major Business
2.9.3 Veritas Genetics Prenatal Screening Product and Solutions
2.9.4 Veritas Genetics Prenatal Screening Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Veritas Genetics Recent Developments and Future Plans
2.10 GGA
2.10.1 GGA Details
2.10.2 GGA Major Business
2.10.3 GGA Prenatal Screening Product and Solutions
2.10.4 GGA Prenatal Screening Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 GGA Recent Developments and Future Plans
2.11 Cordlife
2.11.1 Cordlife Details
2.11.2 Cordlife Major Business
2.11.3 Cordlife Prenatal Screening Product and Solutions
2.11.4 Cordlife Prenatal Screening Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Cordlife Recent Developments and Future Plans
2.12 Rainbow Genomics
2.12.1 Rainbow Genomics Details
2.12.2 Rainbow Genomics Major Business
2.12.3 Rainbow Genomics Prenatal Screening Product and Solutions
2.12.4 Rainbow Genomics Prenatal Screening Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Rainbow Genomics Recent Developments and Future Plans
2.13 BGI Genomics
2.13.1 BGI Genomics Details
2.13.2 BGI Genomics Major Business
2.13.3 BGI Genomics Prenatal Screening Product and Solutions
2.13.4 BGI Genomics Prenatal Screening Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 BGI Genomics Recent Developments and Future Plans
2.14 Berry Genomics
2.14.1 Berry Genomics Details
2.14.2 Berry Genomics Major Business
2.14.3 Berry Genomics Prenatal Screening Product and Solutions
2.14.4 Berry Genomics Prenatal Screening Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Berry Genomics Recent Developments and Future Plans
2.15 Annaroad
2.15.1 Annaroad Details
2.15.2 Annaroad Major Business
2.15.3 Annaroad Prenatal Screening Product and Solutions
2.15.4 Annaroad Prenatal Screening Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 Annaroad Recent Developments and Future Plans
2.16 Jiajian Medical Testing
2.16.1 Jiajian Medical Testing Details
2.16.2 Jiajian Medical Testing Major Business
2.16.3 Jiajian Medical Testing Prenatal Screening Product and Solutions
2.16.4 Jiajian Medical Testing Prenatal Screening Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 Jiajian Medical Testing Recent Developments and Future Plans
2.17 Genesky
2.17.1 Genesky Details
2.17.2 Genesky Major Business
2.17.3 Genesky Prenatal Screening Product and Solutions
2.17.4 Genesky Prenatal Screening Revenue, Gross Margin and Market Share (2021-2026)
2.17.5 Genesky Recent Developments and Future Plans
2.18 Weihansi Biomedical Technology
2.18.1 Weihansi Biomedical Technology Details
2.18.2 Weihansi Biomedical Technology Major Business
2.18.3 Weihansi Biomedical Technology Prenatal Screening Product and Solutions
2.18.4 Weihansi Biomedical Technology Prenatal Screening Revenue, Gross Margin and Market Share (2021-2026)
2.18.5 Weihansi Biomedical Technology Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Prenatal Screening Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Prenatal Screening by Company Revenue
3.2.2 Top 3 Prenatal Screening Players Market Share in 2025
3.2.3 Top 6 Prenatal Screening Players Market Share in 2025
3.3 Prenatal Screening Market: Overall Company Footprint Analysis
3.3.1 Prenatal Screening Market: Region Footprint
3.3.2 Prenatal Screening Market: Company Product Type Footprint
3.3.3 Prenatal Screening Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Prenatal Screening Consumption Value and Market Share by Type (2021-2026)
4.2 Global Prenatal Screening Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Prenatal Screening Consumption Value Market Share by Application (2021-2026)
5.2 Global Prenatal Screening Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America Prenatal Screening Consumption Value by Type (2021-2032)
6.2 North America Prenatal Screening Market Size by Application (2021-2032)
6.3 North America Prenatal Screening Market Size by Country
6.3.1 North America Prenatal Screening Consumption Value by Country (2021-2032)
6.3.2 United States Prenatal Screening Market Size and Forecast (2021-2032)
6.3.3 Canada Prenatal Screening Market Size and Forecast (2021-2032)
6.3.4 Mexico Prenatal Screening Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe Prenatal Screening Consumption Value by Type (2021-2032)
7.2 Europe Prenatal Screening Consumption Value by Application (2021-2032)
7.3 Europe Prenatal Screening Market Size by Country
7.3.1 Europe Prenatal Screening Consumption Value by Country (2021-2032)
7.3.2 Germany Prenatal Screening Market Size and Forecast (2021-2032)
7.3.3 France Prenatal Screening Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Prenatal Screening Market Size and Forecast (2021-2032)
7.3.5 Russia Prenatal Screening Market Size and Forecast (2021-2032)
7.3.6 Italy Prenatal Screening Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific Prenatal Screening Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Prenatal Screening Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Prenatal Screening Market Size by Region
8.3.1 Asia-Pacific Prenatal Screening Consumption Value by Region (2021-2032)
8.3.2 China Prenatal Screening Market Size and Forecast (2021-2032)
8.3.3 Japan Prenatal Screening Market Size and Forecast (2021-2032)
8.3.4 South Korea Prenatal Screening Market Size and Forecast (2021-2032)
8.3.5 India Prenatal Screening Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Prenatal Screening Market Size and Forecast (2021-2032)
8.3.7 Australia Prenatal Screening Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America Prenatal Screening Consumption Value by Type (2021-2032)
9.2 South America Prenatal Screening Consumption Value by Application (2021-2032)
9.3 South America Prenatal Screening Market Size by Country
9.3.1 South America Prenatal Screening Consumption Value by Country (2021-2032)
9.3.2 Brazil Prenatal Screening Market Size and Forecast (2021-2032)
9.3.3 Argentina Prenatal Screening Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Prenatal Screening Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Prenatal Screening Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Prenatal Screening Market Size by Country
10.3.1 Middle East & Africa Prenatal Screening Consumption Value by Country (2021-2032)
10.3.2 Turkey Prenatal Screening Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Prenatal Screening Market Size and Forecast (2021-2032)
10.3.4 UAE Prenatal Screening Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 Prenatal Screening Market Drivers
11.2 Prenatal Screening Market Restraints
11.3 Prenatal Screening Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Prenatal Screening Industry Chain
12.2 Prenatal Screening Upstream Analysis
12.3 Prenatal Screening Midstream Analysis
12.4 Prenatal Screening Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Prenatal Screening Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Prenatal Screening Consumption Value by Screening Timing, (USD Million), 2021 & 2025 & 2032
Table 3. Global Prenatal Screening Consumption Value by Service Model, (USD Million), 2021 & 2025 & 2032
Table 4. Global Prenatal Screening Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Global Prenatal Screening Consumption Value by Region (2021-2026) & (USD Million)
Table 6. Global Prenatal Screening Consumption Value by Region (2027-2032) & (USD Million)
Table 7. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 8. Thermo Fisher Scientific Major Business
Table 9. Thermo Fisher Scientific Prenatal Screening Product and Solutions
Table 10. Thermo Fisher Scientific Prenatal Screening Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 11. Thermo Fisher Scientific Recent Developments and Future Plans
Table 12. Revvity Company Information, Head Office, and Major Competitors
Table 13. Revvity Major Business
Table 14. Revvity Prenatal Screening Product and Solutions
Table 15. Revvity Prenatal Screening Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 16. Revvity Recent Developments and Future Plans
Table 17. Quest Diagnostics Company Information, Head Office, and Major Competitors
Table 18. Quest Diagnostics Major Business
Table 19. Quest Diagnostics Prenatal Screening Product and Solutions
Table 20. Quest Diagnostics Prenatal Screening Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 21. MedGenome Company Information, Head Office, and Major Competitors
Table 22. MedGenome Major Business
Table 23. MedGenome Prenatal Screening Product and Solutions
Table 24. MedGenome Prenatal Screening Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 25. MedGenome Recent Developments and Future Plans
Table 26. Mayo Clinic Laboratories Company Information, Head Office, and Major Competitors
Table 27. Mayo Clinic Laboratories Major Business
Table 28. Mayo Clinic Laboratories Prenatal Screening Product and Solutions
Table 29. Mayo Clinic Laboratories Prenatal Screening Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 30. Mayo Clinic Laboratories Recent Developments and Future Plans
Table 31. GeneDx Company Information, Head Office, and Major Competitors
Table 32. GeneDx Major Business
Table 33. GeneDx Prenatal Screening Product and Solutions
Table 34. GeneDx Prenatal Screening Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 35. GeneDx Recent Developments and Future Plans
Table 36. PreventionGenetics Company Information, Head Office, and Major Competitors
Table 37. PreventionGenetics Major Business
Table 38. PreventionGenetics Prenatal Screening Product and Solutions
Table 39. PreventionGenetics Prenatal Screening Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 40. PreventionGenetics Recent Developments and Future Plans
Table 41. SYNLAB Company Information, Head Office, and Major Competitors
Table 42. SYNLAB Major Business
Table 43. SYNLAB Prenatal Screening Product and Solutions
Table 44. SYNLAB Prenatal Screening Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 45. SYNLAB Recent Developments and Future Plans
Table 46. Veritas Genetics Company Information, Head Office, and Major Competitors
Table 47. Veritas Genetics Major Business
Table 48. Veritas Genetics Prenatal Screening Product and Solutions
Table 49. Veritas Genetics Prenatal Screening Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 50. Veritas Genetics Recent Developments and Future Plans
Table 51. GGA Company Information, Head Office, and Major Competitors
Table 52. GGA Major Business
Table 53. GGA Prenatal Screening Product and Solutions
Table 54. GGA Prenatal Screening Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 55. GGA Recent Developments and Future Plans
Table 56. Cordlife Company Information, Head Office, and Major Competitors
Table 57. Cordlife Major Business
Table 58. Cordlife Prenatal Screening Product and Solutions
Table 59. Cordlife Prenatal Screening Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 60. Cordlife Recent Developments and Future Plans
Table 61. Rainbow Genomics Company Information, Head Office, and Major Competitors
Table 62. Rainbow Genomics Major Business
Table 63. Rainbow Genomics Prenatal Screening Product and Solutions
Table 64. Rainbow Genomics Prenatal Screening Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. Rainbow Genomics Recent Developments and Future Plans
Table 66. BGI Genomics Company Information, Head Office, and Major Competitors
Table 67. BGI Genomics Major Business
Table 68. BGI Genomics Prenatal Screening Product and Solutions
Table 69. BGI Genomics Prenatal Screening Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 70. BGI Genomics Recent Developments and Future Plans
Table 71. Berry Genomics Company Information, Head Office, and Major Competitors
Table 72. Berry Genomics Major Business
Table 73. Berry Genomics Prenatal Screening Product and Solutions
Table 74. Berry Genomics Prenatal Screening Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 75. Berry Genomics Recent Developments and Future Plans
Table 76. Annaroad Company Information, Head Office, and Major Competitors
Table 77. Annaroad Major Business
Table 78. Annaroad Prenatal Screening Product and Solutions
Table 79. Annaroad Prenatal Screening Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 80. Annaroad Recent Developments and Future Plans
Table 81. Jiajian Medical Testing Company Information, Head Office, and Major Competitors
Table 82. Jiajian Medical Testing Major Business
Table 83. Jiajian Medical Testing Prenatal Screening Product and Solutions
Table 84. Jiajian Medical Testing Prenatal Screening Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Jiajian Medical Testing Recent Developments and Future Plans
Table 86. Genesky Company Information, Head Office, and Major Competitors
Table 87. Genesky Major Business
Table 88. Genesky Prenatal Screening Product and Solutions
Table 89. Genesky Prenatal Screening Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 90. Genesky Recent Developments and Future Plans
Table 91. Weihansi Biomedical Technology Company Information, Head Office, and Major Competitors
Table 92. Weihansi Biomedical Technology Major Business
Table 93. Weihansi Biomedical Technology Prenatal Screening Product and Solutions
Table 94. Weihansi Biomedical Technology Prenatal Screening Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 95. Weihansi Biomedical Technology Recent Developments and Future Plans
Table 96. Global Prenatal Screening Revenue (USD Million) by Players (2021-2026)
Table 97. Global Prenatal Screening Revenue Share by Players (2021-2026)
Table 98. Breakdown of Prenatal Screening by Company Type (Tier 1, Tier 2, and Tier 3)
Table 99. Market Position of Players in Prenatal Screening, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 100. Head Office of Key Prenatal Screening Players
Table 101. Prenatal Screening Market: Company Product Type Footprint
Table 102. Prenatal Screening Market: Company Product Application Footprint
Table 103. Prenatal Screening New Market Entrants and Barriers to Market Entry
Table 104. Prenatal Screening Mergers, Acquisition, Agreements, and Collaborations
Table 105. Global Prenatal Screening Consumption Value (USD Million) by Type (2021-2026)
Table 106. Global Prenatal Screening Consumption Value Share by Type (2021-2026)
Table 107. Global Prenatal Screening Consumption Value Forecast by Type (2027-2032)
Table 108. Global Prenatal Screening Consumption Value by Application (2021-2026)
Table 109. Global Prenatal Screening Consumption Value Forecast by Application (2027-2032)
Table 110. North America Prenatal Screening Consumption Value by Type (2021-2026) & (USD Million)
Table 111. North America Prenatal Screening Consumption Value by Type (2027-2032) & (USD Million)
Table 112. North America Prenatal Screening Consumption Value by Application (2021-2026) & (USD Million)
Table 113. North America Prenatal Screening Consumption Value by Application (2027-2032) & (USD Million)
Table 114. North America Prenatal Screening Consumption Value by Country (2021-2026) & (USD Million)
Table 115. North America Prenatal Screening Consumption Value by Country (2027-2032) & (USD Million)
Table 116. Europe Prenatal Screening Consumption Value by Type (2021-2026) & (USD Million)
Table 117. Europe Prenatal Screening Consumption Value by Type (2027-2032) & (USD Million)
Table 118. Europe Prenatal Screening Consumption Value by Application (2021-2026) & (USD Million)
Table 119. Europe Prenatal Screening Consumption Value by Application (2027-2032) & (USD Million)
Table 120. Europe Prenatal Screening Consumption Value by Country (2021-2026) & (USD Million)
Table 121. Europe Prenatal Screening Consumption Value by Country (2027-2032) & (USD Million)
Table 122. Asia-Pacific Prenatal Screening Consumption Value by Type (2021-2026) & (USD Million)
Table 123. Asia-Pacific Prenatal Screening Consumption Value by Type (2027-2032) & (USD Million)
Table 124. Asia-Pacific Prenatal Screening Consumption Value by Application (2021-2026) & (USD Million)
Table 125. Asia-Pacific Prenatal Screening Consumption Value by Application (2027-2032) & (USD Million)
Table 126. Asia-Pacific Prenatal Screening Consumption Value by Region (2021-2026) & (USD Million)
Table 127. Asia-Pacific Prenatal Screening Consumption Value by Region (2027-2032) & (USD Million)
Table 128. South America Prenatal Screening Consumption Value by Type (2021-2026) & (USD Million)
Table 129. South America Prenatal Screening Consumption Value by Type (2027-2032) & (USD Million)
Table 130. South America Prenatal Screening Consumption Value by Application (2021-2026) & (USD Million)
Table 131. South America Prenatal Screening Consumption Value by Application (2027-2032) & (USD Million)
Table 132. South America Prenatal Screening Consumption Value by Country (2021-2026) & (USD Million)
Table 133. South America Prenatal Screening Consumption Value by Country (2027-2032) & (USD Million)
Table 134. Middle East & Africa Prenatal Screening Consumption Value by Type (2021-2026) & (USD Million)
Table 135. Middle East & Africa Prenatal Screening Consumption Value by Type (2027-2032) & (USD Million)
Table 136. Middle East & Africa Prenatal Screening Consumption Value by Application (2021-2026) & (USD Million)
Table 137. Middle East & Africa Prenatal Screening Consumption Value by Application (2027-2032) & (USD Million)
Table 138. Middle East & Africa Prenatal Screening Consumption Value by Country (2021-2026) & (USD Million)
Table 139. Middle East & Africa Prenatal Screening Consumption Value by Country (2027-2032) & (USD Million)
Table 140. Global Key Players of Prenatal Screening Upstream (Raw Materials)
Table 141. Global Prenatal Screening Typical Customers
Table 1. Global Prenatal Screening Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Prenatal Screening Consumption Value by Screening Timing, (USD Million), 2021 & 2025 & 2032
Table 3. Global Prenatal Screening Consumption Value by Service Model, (USD Million), 2021 & 2025 & 2032
Table 4. Global Prenatal Screening Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Global Prenatal Screening Consumption Value by Region (2021-2026) & (USD Million)
Table 6. Global Prenatal Screening Consumption Value by Region (2027-2032) & (USD Million)
Table 7. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 8. Thermo Fisher Scientific Major Business
Table 9. Thermo Fisher Scientific Prenatal Screening Product and Solutions
Table 10. Thermo Fisher Scientific Prenatal Screening Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 11. Thermo Fisher Scientific Recent Developments and Future Plans
Table 12. Revvity Company Information, Head Office, and Major Competitors
Table 13. Revvity Major Business
Table 14. Revvity Prenatal Screening Product and Solutions
Table 15. Revvity Prenatal Screening Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 16. Revvity Recent Developments and Future Plans
Table 17. Quest Diagnostics Company Information, Head Office, and Major Competitors
Table 18. Quest Diagnostics Major Business
Table 19. Quest Diagnostics Prenatal Screening Product and Solutions
Table 20. Quest Diagnostics Prenatal Screening Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 21. MedGenome Company Information, Head Office, and Major Competitors
Table 22. MedGenome Major Business
Table 23. MedGenome Prenatal Screening Product and Solutions
Table 24. MedGenome Prenatal Screening Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 25. MedGenome Recent Developments and Future Plans
Table 26. Mayo Clinic Laboratories Company Information, Head Office, and Major Competitors
Table 27. Mayo Clinic Laboratories Major Business
Table 28. Mayo Clinic Laboratories Prenatal Screening Product and Solutions
Table 29. Mayo Clinic Laboratories Prenatal Screening Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 30. Mayo Clinic Laboratories Recent Developments and Future Plans
Table 31. GeneDx Company Information, Head Office, and Major Competitors
Table 32. GeneDx Major Business
Table 33. GeneDx Prenatal Screening Product and Solutions
Table 34. GeneDx Prenatal Screening Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 35. GeneDx Recent Developments and Future Plans
Table 36. PreventionGenetics Company Information, Head Office, and Major Competitors
Table 37. PreventionGenetics Major Business
Table 38. PreventionGenetics Prenatal Screening Product and Solutions
Table 39. PreventionGenetics Prenatal Screening Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 40. PreventionGenetics Recent Developments and Future Plans
Table 41. SYNLAB Company Information, Head Office, and Major Competitors
Table 42. SYNLAB Major Business
Table 43. SYNLAB Prenatal Screening Product and Solutions
Table 44. SYNLAB Prenatal Screening Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 45. SYNLAB Recent Developments and Future Plans
Table 46. Veritas Genetics Company Information, Head Office, and Major Competitors
Table 47. Veritas Genetics Major Business
Table 48. Veritas Genetics Prenatal Screening Product and Solutions
Table 49. Veritas Genetics Prenatal Screening Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 50. Veritas Genetics Recent Developments and Future Plans
Table 51. GGA Company Information, Head Office, and Major Competitors
Table 52. GGA Major Business
Table 53. GGA Prenatal Screening Product and Solutions
Table 54. GGA Prenatal Screening Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 55. GGA Recent Developments and Future Plans
Table 56. Cordlife Company Information, Head Office, and Major Competitors
Table 57. Cordlife Major Business
Table 58. Cordlife Prenatal Screening Product and Solutions
Table 59. Cordlife Prenatal Screening Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 60. Cordlife Recent Developments and Future Plans
Table 61. Rainbow Genomics Company Information, Head Office, and Major Competitors
Table 62. Rainbow Genomics Major Business
Table 63. Rainbow Genomics Prenatal Screening Product and Solutions
Table 64. Rainbow Genomics Prenatal Screening Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. Rainbow Genomics Recent Developments and Future Plans
Table 66. BGI Genomics Company Information, Head Office, and Major Competitors
Table 67. BGI Genomics Major Business
Table 68. BGI Genomics Prenatal Screening Product and Solutions
Table 69. BGI Genomics Prenatal Screening Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 70. BGI Genomics Recent Developments and Future Plans
Table 71. Berry Genomics Company Information, Head Office, and Major Competitors
Table 72. Berry Genomics Major Business
Table 73. Berry Genomics Prenatal Screening Product and Solutions
Table 74. Berry Genomics Prenatal Screening Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 75. Berry Genomics Recent Developments and Future Plans
Table 76. Annaroad Company Information, Head Office, and Major Competitors
Table 77. Annaroad Major Business
Table 78. Annaroad Prenatal Screening Product and Solutions
Table 79. Annaroad Prenatal Screening Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 80. Annaroad Recent Developments and Future Plans
Table 81. Jiajian Medical Testing Company Information, Head Office, and Major Competitors
Table 82. Jiajian Medical Testing Major Business
Table 83. Jiajian Medical Testing Prenatal Screening Product and Solutions
Table 84. Jiajian Medical Testing Prenatal Screening Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Jiajian Medical Testing Recent Developments and Future Plans
Table 86. Genesky Company Information, Head Office, and Major Competitors
Table 87. Genesky Major Business
Table 88. Genesky Prenatal Screening Product and Solutions
Table 89. Genesky Prenatal Screening Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 90. Genesky Recent Developments and Future Plans
Table 91. Weihansi Biomedical Technology Company Information, Head Office, and Major Competitors
Table 92. Weihansi Biomedical Technology Major Business
Table 93. Weihansi Biomedical Technology Prenatal Screening Product and Solutions
Table 94. Weihansi Biomedical Technology Prenatal Screening Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 95. Weihansi Biomedical Technology Recent Developments and Future Plans
Table 96. Global Prenatal Screening Revenue (USD Million) by Players (2021-2026)
Table 97. Global Prenatal Screening Revenue Share by Players (2021-2026)
Table 98. Breakdown of Prenatal Screening by Company Type (Tier 1, Tier 2, and Tier 3)
Table 99. Market Position of Players in Prenatal Screening, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 100. Head Office of Key Prenatal Screening Players
Table 101. Prenatal Screening Market: Company Product Type Footprint
Table 102. Prenatal Screening Market: Company Product Application Footprint
Table 103. Prenatal Screening New Market Entrants and Barriers to Market Entry
Table 104. Prenatal Screening Mergers, Acquisition, Agreements, and Collaborations
Table 105. Global Prenatal Screening Consumption Value (USD Million) by Type (2021-2026)
Table 106. Global Prenatal Screening Consumption Value Share by Type (2021-2026)
Table 107. Global Prenatal Screening Consumption Value Forecast by Type (2027-2032)
Table 108. Global Prenatal Screening Consumption Value by Application (2021-2026)
Table 109. Global Prenatal Screening Consumption Value Forecast by Application (2027-2032)
Table 110. North America Prenatal Screening Consumption Value by Type (2021-2026) & (USD Million)
Table 111. North America Prenatal Screening Consumption Value by Type (2027-2032) & (USD Million)
Table 112. North America Prenatal Screening Consumption Value by Application (2021-2026) & (USD Million)
Table 113. North America Prenatal Screening Consumption Value by Application (2027-2032) & (USD Million)
Table 114. North America Prenatal Screening Consumption Value by Country (2021-2026) & (USD Million)
Table 115. North America Prenatal Screening Consumption Value by Country (2027-2032) & (USD Million)
Table 116. Europe Prenatal Screening Consumption Value by Type (2021-2026) & (USD Million)
Table 117. Europe Prenatal Screening Consumption Value by Type (2027-2032) & (USD Million)
Table 118. Europe Prenatal Screening Consumption Value by Application (2021-2026) & (USD Million)
Table 119. Europe Prenatal Screening Consumption Value by Application (2027-2032) & (USD Million)
Table 120. Europe Prenatal Screening Consumption Value by Country (2021-2026) & (USD Million)
Table 121. Europe Prenatal Screening Consumption Value by Country (2027-2032) & (USD Million)
Table 122. Asia-Pacific Prenatal Screening Consumption Value by Type (2021-2026) & (USD Million)
Table 123. Asia-Pacific Prenatal Screening Consumption Value by Type (2027-2032) & (USD Million)
Table 124. Asia-Pacific Prenatal Screening Consumption Value by Application (2021-2026) & (USD Million)
Table 125. Asia-Pacific Prenatal Screening Consumption Value by Application (2027-2032) & (USD Million)
Table 126. Asia-Pacific Prenatal Screening Consumption Value by Region (2021-2026) & (USD Million)
Table 127. Asia-Pacific Prenatal Screening Consumption Value by Region (2027-2032) & (USD Million)
Table 128. South America Prenatal Screening Consumption Value by Type (2021-2026) & (USD Million)
Table 129. South America Prenatal Screening Consumption Value by Type (2027-2032) & (USD Million)
Table 130. South America Prenatal Screening Consumption Value by Application (2021-2026) & (USD Million)
Table 131. South America Prenatal Screening Consumption Value by Application (2027-2032) & (USD Million)
Table 132. South America Prenatal Screening Consumption Value by Country (2021-2026) & (USD Million)
Table 133. South America Prenatal Screening Consumption Value by Country (2027-2032) & (USD Million)
Table 134. Middle East & Africa Prenatal Screening Consumption Value by Type (2021-2026) & (USD Million)
Table 135. Middle East & Africa Prenatal Screening Consumption Value by Type (2027-2032) & (USD Million)
Table 136. Middle East & Africa Prenatal Screening Consumption Value by Application (2021-2026) & (USD Million)
Table 137. Middle East & Africa Prenatal Screening Consumption Value by Application (2027-2032) & (USD Million)
Table 138. Middle East & Africa Prenatal Screening Consumption Value by Country (2021-2026) & (USD Million)
Table 139. Middle East & Africa Prenatal Screening Consumption Value by Country (2027-2032) & (USD Million)
Table 140. Global Key Players of Prenatal Screening Upstream (Raw Materials)
Table 141. Global Prenatal Screening Typical Customers
LIST OF FIGURES
Figure 1. Prenatal Screening Picture
Figure 2. Global Prenatal Screening Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Prenatal Screening Consumption Value Market Share by Type in 2025
Figure 4. Serum Biomarker Screening
Figure 5. Ultrasonographic Imaging Screening
Figure 6. Others
Figure 7. Global Prenatal Screening Consumption Value by Screening Timing, (USD Million), 2021 & 2025 & 2032
Figure 8. Global Prenatal Screening Consumption Value Market Share by Screening Timing in 2025
Figure 9. First-trimester Screening
Figure 10. Second-trimester Screening
Figure 11. Late-pregnancy Screening
Figure 12. Global Prenatal Screening Consumption Value by Service Model, (USD Million), 2021 & 2025 & 2032
Figure 13. Global Prenatal Screening Consumption Value Market Share by Service Model in 2025
Figure 14. Public Health Program
Figure 15. Consumer
Figure 16. Others
Figure 17. Global Prenatal Screening Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 18. Prenatal Screening Consumption Value Market Share by Application in 2025
Figure 19. Public Hospitals Picture
Figure 20. Private Hospitals Picture
Figure 21. Global Prenatal Screening Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 22. Global Prenatal Screening Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 23. Global Market Prenatal Screening Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 24. Global Prenatal Screening Consumption Value Market Share by Region (2021-2032)
Figure 25. Global Prenatal Screening Consumption Value Market Share by Region in 2025
Figure 26. North America Prenatal Screening Consumption Value (2021-2032) & (USD Million)
Figure 27. Europe Prenatal Screening Consumption Value (2021-2032) & (USD Million)
Figure 28. Asia-Pacific Prenatal Screening Consumption Value (2021-2032) & (USD Million)
Figure 29. South America Prenatal Screening Consumption Value (2021-2032) & (USD Million)
Figure 30. Middle East & Africa Prenatal Screening Consumption Value (2021-2032) & (USD Million)
Figure 31. Company Three Recent Developments and Future Plans
Figure 32. Global Prenatal Screening Revenue Share by Players in 2025
Figure 33. Prenatal Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 34. Market Share of Prenatal Screening by Player Revenue in 2025
Figure 35. Top 3 Prenatal Screening Players Market Share in 2025
Figure 36. Top 6 Prenatal Screening Players Market Share in 2025
Figure 37. Global Prenatal Screening Consumption Value Share by Type (2021-2026)
Figure 38. Global Prenatal Screening Market Share Forecast by Type (2027-2032)
Figure 39. Global Prenatal Screening Consumption Value Share by Application (2021-2026)
Figure 40. Global Prenatal Screening Market Share Forecast by Application (2027-2032)
Figure 41. North America Prenatal Screening Consumption Value Market Share by Type (2021-2032)
Figure 42. North America Prenatal Screening Consumption Value Market Share by Application (2021-2032)
Figure 43. North America Prenatal Screening Consumption Value Market Share by Country (2021-2032)
Figure 44. United States Prenatal Screening Consumption Value (2021-2032) & (USD Million)
Figure 45. Canada Prenatal Screening Consumption Value (2021-2032) & (USD Million)
Figure 46. Mexico Prenatal Screening Consumption Value (2021-2032) & (USD Million)
Figure 47. Europe Prenatal Screening Consumption Value Market Share by Type (2021-2032)
Figure 48. Europe Prenatal Screening Consumption Value Market Share by Application (2021-2032)
Figure 49. Europe Prenatal Screening Consumption Value Market Share by Country (2021-2032)
Figure 50. Germany Prenatal Screening Consumption Value (2021-2032) & (USD Million)
Figure 51. France Prenatal Screening Consumption Value (2021-2032) & (USD Million)
Figure 52. United Kingdom Prenatal Screening Consumption Value (2021-2032) & (USD Million)
Figure 53. Russia Prenatal Screening Consumption Value (2021-2032) & (USD Million)
Figure 54. Italy Prenatal Screening Consumption Value (2021-2032) & (USD Million)
Figure 55. Asia-Pacific Prenatal Screening Consumption Value Market Share by Type (2021-2032)
Figure 56. Asia-Pacific Prenatal Screening Consumption Value Market Share by Application (2021-2032)
Figure 57. Asia-Pacific Prenatal Screening Consumption Value Market Share by Region (2021-2032)
Figure 58. China Prenatal Screening Consumption Value (2021-2032) & (USD Million)
Figure 59. Japan Prenatal Screening Consumption Value (2021-2032) & (USD Million)
Figure 60. South Korea Prenatal Screening Consumption Value (2021-2032) & (USD Million)
Figure 61. India Prenatal Screening Consumption Value (2021-2032) & (USD Million)
Figure 62. Southeast Asia Prenatal Screening Consumption Value (2021-2032) & (USD Million)
Figure 63. Australia Prenatal Screening Consumption Value (2021-2032) & (USD Million)
Figure 64. South America Prenatal Screening Consumption Value Market Share by Type (2021-2032)
Figure 65. South America Prenatal Screening Consumption Value Market Share by Application (2021-2032)
Figure 66. South America Prenatal Screening Consumption Value Market Share by Country (2021-2032)
Figure 67. Brazil Prenatal Screening Consumption Value (2021-2032) & (USD Million)
Figure 68. Argentina Prenatal Screening Consumption Value (2021-2032) & (USD Million)
Figure 69. Middle East & Africa Prenatal Screening Consumption Value Market Share by Type (2021-2032)
Figure 70. Middle East & Africa Prenatal Screening Consumption Value Market Share by Application (2021-2032)
Figure 71. Middle East & Africa Prenatal Screening Consumption Value Market Share by Country (2021-2032)
Figure 72. Turkey Prenatal Screening Consumption Value (2021-2032) & (USD Million)
Figure 73. Saudi Arabia Prenatal Screening Consumption Value (2021-2032) & (USD Million)
Figure 74. UAE Prenatal Screening Consumption Value (2021-2032) & (USD Million)
Figure 75. Prenatal Screening Market Drivers
Figure 76. Prenatal Screening Market Restraints
Figure 77. Prenatal Screening Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Prenatal Screening Industrial Chain
Figure 80. Methodology
Figure 81. Research Process and Data Source
Figure 1. Prenatal Screening Picture
Figure 2. Global Prenatal Screening Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Prenatal Screening Consumption Value Market Share by Type in 2025
Figure 4. Serum Biomarker Screening
Figure 5. Ultrasonographic Imaging Screening
Figure 6. Others
Figure 7. Global Prenatal Screening Consumption Value by Screening Timing, (USD Million), 2021 & 2025 & 2032
Figure 8. Global Prenatal Screening Consumption Value Market Share by Screening Timing in 2025
Figure 9. First-trimester Screening
Figure 10. Second-trimester Screening
Figure 11. Late-pregnancy Screening
Figure 12. Global Prenatal Screening Consumption Value by Service Model, (USD Million), 2021 & 2025 & 2032
Figure 13. Global Prenatal Screening Consumption Value Market Share by Service Model in 2025
Figure 14. Public Health Program
Figure 15. Consumer
Figure 16. Others
Figure 17. Global Prenatal Screening Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 18. Prenatal Screening Consumption Value Market Share by Application in 2025
Figure 19. Public Hospitals Picture
Figure 20. Private Hospitals Picture
Figure 21. Global Prenatal Screening Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 22. Global Prenatal Screening Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 23. Global Market Prenatal Screening Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 24. Global Prenatal Screening Consumption Value Market Share by Region (2021-2032)
Figure 25. Global Prenatal Screening Consumption Value Market Share by Region in 2025
Figure 26. North America Prenatal Screening Consumption Value (2021-2032) & (USD Million)
Figure 27. Europe Prenatal Screening Consumption Value (2021-2032) & (USD Million)
Figure 28. Asia-Pacific Prenatal Screening Consumption Value (2021-2032) & (USD Million)
Figure 29. South America Prenatal Screening Consumption Value (2021-2032) & (USD Million)
Figure 30. Middle East & Africa Prenatal Screening Consumption Value (2021-2032) & (USD Million)
Figure 31. Company Three Recent Developments and Future Plans
Figure 32. Global Prenatal Screening Revenue Share by Players in 2025
Figure 33. Prenatal Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 34. Market Share of Prenatal Screening by Player Revenue in 2025
Figure 35. Top 3 Prenatal Screening Players Market Share in 2025
Figure 36. Top 6 Prenatal Screening Players Market Share in 2025
Figure 37. Global Prenatal Screening Consumption Value Share by Type (2021-2026)
Figure 38. Global Prenatal Screening Market Share Forecast by Type (2027-2032)
Figure 39. Global Prenatal Screening Consumption Value Share by Application (2021-2026)
Figure 40. Global Prenatal Screening Market Share Forecast by Application (2027-2032)
Figure 41. North America Prenatal Screening Consumption Value Market Share by Type (2021-2032)
Figure 42. North America Prenatal Screening Consumption Value Market Share by Application (2021-2032)
Figure 43. North America Prenatal Screening Consumption Value Market Share by Country (2021-2032)
Figure 44. United States Prenatal Screening Consumption Value (2021-2032) & (USD Million)
Figure 45. Canada Prenatal Screening Consumption Value (2021-2032) & (USD Million)
Figure 46. Mexico Prenatal Screening Consumption Value (2021-2032) & (USD Million)
Figure 47. Europe Prenatal Screening Consumption Value Market Share by Type (2021-2032)
Figure 48. Europe Prenatal Screening Consumption Value Market Share by Application (2021-2032)
Figure 49. Europe Prenatal Screening Consumption Value Market Share by Country (2021-2032)
Figure 50. Germany Prenatal Screening Consumption Value (2021-2032) & (USD Million)
Figure 51. France Prenatal Screening Consumption Value (2021-2032) & (USD Million)
Figure 52. United Kingdom Prenatal Screening Consumption Value (2021-2032) & (USD Million)
Figure 53. Russia Prenatal Screening Consumption Value (2021-2032) & (USD Million)
Figure 54. Italy Prenatal Screening Consumption Value (2021-2032) & (USD Million)
Figure 55. Asia-Pacific Prenatal Screening Consumption Value Market Share by Type (2021-2032)
Figure 56. Asia-Pacific Prenatal Screening Consumption Value Market Share by Application (2021-2032)
Figure 57. Asia-Pacific Prenatal Screening Consumption Value Market Share by Region (2021-2032)
Figure 58. China Prenatal Screening Consumption Value (2021-2032) & (USD Million)
Figure 59. Japan Prenatal Screening Consumption Value (2021-2032) & (USD Million)
Figure 60. South Korea Prenatal Screening Consumption Value (2021-2032) & (USD Million)
Figure 61. India Prenatal Screening Consumption Value (2021-2032) & (USD Million)
Figure 62. Southeast Asia Prenatal Screening Consumption Value (2021-2032) & (USD Million)
Figure 63. Australia Prenatal Screening Consumption Value (2021-2032) & (USD Million)
Figure 64. South America Prenatal Screening Consumption Value Market Share by Type (2021-2032)
Figure 65. South America Prenatal Screening Consumption Value Market Share by Application (2021-2032)
Figure 66. South America Prenatal Screening Consumption Value Market Share by Country (2021-2032)
Figure 67. Brazil Prenatal Screening Consumption Value (2021-2032) & (USD Million)
Figure 68. Argentina Prenatal Screening Consumption Value (2021-2032) & (USD Million)
Figure 69. Middle East & Africa Prenatal Screening Consumption Value Market Share by Type (2021-2032)
Figure 70. Middle East & Africa Prenatal Screening Consumption Value Market Share by Application (2021-2032)
Figure 71. Middle East & Africa Prenatal Screening Consumption Value Market Share by Country (2021-2032)
Figure 72. Turkey Prenatal Screening Consumption Value (2021-2032) & (USD Million)
Figure 73. Saudi Arabia Prenatal Screening Consumption Value (2021-2032) & (USD Million)
Figure 74. UAE Prenatal Screening Consumption Value (2021-2032) & (USD Million)
Figure 75. Prenatal Screening Market Drivers
Figure 76. Prenatal Screening Market Restraints
Figure 77. Prenatal Screening Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Prenatal Screening Industrial Chain
Figure 80. Methodology
Figure 81. Research Process and Data Source
